GTC is proud to present the 2nd Neurological Biomarkers Conference as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the biomarker field related to neuroscience. Topics of this conference include updates on biomarkers in Alzheimer’s disease, CSF and blood-based biomarkers and imaging biomarkers. Biomarker data will also be presented in other specific neurological disorders such as Parkinson’s, MS, ALS, schizophrenia and pain. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:

March 20th

Plenary Keynote Session

Breakout: Neurological Biomarkers

Updates on Biomarkers in Alzheimer’s Disease

CSF / Blood-based Biomarkers

Imaging Biomarkers in Neuroscience

- PET

- MRI /fMRI

Biomarkers in Other Neurological Disorders

- Parkinson’s

- MS

- ALS

- Huntington’s

- Depression

- Schizophrenia

- Pain

Mar 22nd

General Session

Regulatory & Reimbursement Updates in Biomarker Development

+ Panel Discussion

Companion Diagnostics Development & Partnering Strategies

+ Panel Discussion